Methylthioninium chloride Proveblue 5 mg/ml solution for injection – UK Summary of Product Characteristics (PLGB 40051/0002) (2024)

Government Record · Provepharm SAS (marketing authorisation holder); SmPC hosted by Datapharm/emc · May 23, 2024

Provepharm SAS (marketing authorisation holder), 2024-05-23: The Great Britain SmPC for Methylthioninium chloride Proveblue gives UK licence number PLGB 40051/0002, holder Provepharm SAS, and a first authorisation date of 1 January 2021, with text revised 23 May 2024.

7. Marketing authorisation holder PROVEPHARM SAS 22 rue Marc Donadille, 13013 Marseille, France 8. Marketing authorisation number(s) PLGB 40051/0002 9. Date of first authorisation/renewal of the authorisation 01/01/2021

Provepharm SAS (marketing authorisation holder), 2024-05-23: The Great Britain SmPC for Methylthioninium chloride Proveblue gives UK licence number PLGB 40051/0002, holder Provepharm SAS, and a first authorisation date of 1 January 2021, with text revised 23 May 2024. C7 – UK/MHRA route. The PLGB prefix indicates a Great Britain licence granted through the post-Brexit conversion/GB national procedure, separate from the EU/1/11/682 central authorisation; first authorisation date 01/01/2021 is the GB licence date, not the 2011 EU date. SmPC revision date 23/05/2024; manufacturer/labeler named in the page metadata as Provepharm UK Ltd, First Floor, Building 2, Croxley Business Park, Watford WD18 8YA. emc reproduces the MHRA-authorised text; the MHRA product-licence register page itself was not opened (products.mhra.gov.uk). Fetch route: curl then HTML text extraction. Study type: regulatory record.